Michael Droste

Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study

I Schreiber, Michael Buchfelder, Michael Droste et al. · European Journal of Endocrinology · 2007 · 201 citations

Medicine, Endocrinology, Pharmacotherapy +17

Cardiovascular Risk Factors in Patients with Uncontrolled and Long-Term Acromegaly: Comparison with Matched Data from the General Population and the Effect of Disease Control

Christian Berg, Stephan Petersenn, Harald Lahner et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 143 citations · Full text

Medicine, Endocrinology, Internal Medicine +12

GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases

Flavius Zoicas, Michael Droste, B Mayr et al. · European Journal of Endocrinology · 2013 · 123 citations

Medicine, Endocrinology, Pharmacology +16

Diagnosis of Primary Hypophysitis in Germany

Jürgen Honegger, Sven Schlaffer, Christa Menzel et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 122 citations · Full text

Medicine, Endocrinology, Pathology +17

Treatment of Primary Hypophysitis in Germany

Jürgen Honegger, Michael Buchfelder, Sven Schlaffer et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 104 citations · Full text

Medicine, Endocrinology, Surgery +16